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The integration of implanted cartilage is a major challenge for the success of tissue engineering protocols.
We hypothesize that in order for effective cartilage integration to take place, matrix-free chondrocytes
must be induced to migrate between the two tissue surfaces. A chondrocyte/collagen-scaffold implant
system was developed as a method of delivering dividing cells at the interface between two cartilage
surfaces. Chondrocytes were isolated from bovine nasal septum and seeded onto both surfaces of
a collagen membrane to create the chondrocyte/collagen-scaffold implant. A model of two cartilage discs
and the chondrocyte/collagen-scaffold sandwiched in betweenwas used to effect integration in vitro. The
resulting tissue was analysed histologically and biomechanically. The cartilage–implant–cartilage sand-
wich appeared macroscopically as one continuous piece of tissue at the end of 40 day cultures. Histo-
logical analysis showed tissue continuum across the cartilage–scaffold interface. The integration was
dependent on both cells and scaffold. Fluorescent labeling of implanted chondrocytes demonstrated that
these cells invade the surrounding mature tissue and drive a remodelling of the extracellular matrix.
Using cell-free scaffolds we also demonstrated that some chondrocytes migrated from the natural
cartilage into the collagen scaffold. Quantiﬁcation of integration levels using a histomorphometric repair
index showed that the chondrocyte/collagen-scaffold implant achieved the highest repair index
compared to controls, reﬂected functionally through increased tensile strength. In conclusion, cartilage
integration can be achieved using a chondrocyte/collagen-scaffold implant that permits controlled
delivery of chondrocytes to both host and graft mature cartilage tissues. This approach has the potential
to be used therapeutically for implantation of engineered tissue.
 2009 Elsevier Ltd.Open access under CC BY-NC-ND license.1. Introduction
Cartilage tissue engineering provides a potential method for the
production of three-dimensional implants [1,2]. There are two
major biological challenges associated with three-dimensional
cartilage regeneration. The ﬁrst is creating a repair tissue that has
similar structural and mechanical properties to articular cartilage
[3]. To this end, effective engineering protocols have already been
developed in which chondrocytes, usually from young animals, are
seeded onto biodegradable scaffolds and cultured in a bioreactor
[4,5]. More recently, we have demonstrated that it is possible to
engineer hyaline cartilage using bone marrow mesenchymal stem
cells derived from elderly patients with OA [6]. None of these
engineered tissues are identical to natural hyaline cartilage; inx: þ44 117 331 2091.
enah).
Y-NC-ND license.particular they all have a signiﬁcantly lower collagen content than
is found in normal cartilage. However there is evidence that even
very immature tissue engineered cartilage will mature into normal
tissue once implanted inside the joint [7]. The second major
challenge is the need to achieve successful integration across the
interface between the host and repair tissue [8–10]. Integration is
imperative in order to achieve enduring healing and biomechanical
competence [11]. Integrative cartilage repair is thought to be
hindered by the lack of matrix-producing cells in the cartilage–
cartilage interface area [9,12]. This relative acellularity is due to
a combination of chondrocyte loss from lesion edges, avascularity,
and the absence of multipotent progenitor cells. Furthermore, blunt
trauma has been shown to cause apoptosis of chondrocytes in the
defect walls [8,13].
Therefore integration of the repair tissue with surrounding
native cartilage must be considered as a critical step in the devel-
opment of cartilage tissue engineering strategies. Initial, temporary
ﬁxation of an engineered cartilage implant may be achieved using
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between the implant and host cartilage, creating a focus for failure
[10].
In this study we have explored the role of cell migration
between tissue surfaces in driving the process of integration.
Chondrocytes residing within the lacunae of natural or engineered
cartilage do not normally migrate in this way because they are
surrounded by a dense extracellular matrix. Indeed there is
evidence that the more mature the cartilage to be integrated, the
less effective the integration [14]. Previous studies have proposed
coating the surface of engineered cartilage with isolated chon-
drocytes [15–17]. While these cells may have greater propensity to
migrate than endogenous chondrocytes, the number of cells seeded
is difﬁcult to control because they are likely to attach only loosely to
the seeded tissue or clump together, generating only focal
connections between tissue surfaces (unpublished observations).
Therefore, in order to test the hypothesis that integration of
cartilage with cartilage requires cell migration between the two
tissue surfaces, we have developed a chondrocyte/collagen-scaffold
implant in which a thin biodegradable collagen membrane is used
to deliver cells across the integrating zone. We demonstrate that
this approach allows controlled delivery of proliferating cells that
can actively unite one cartilage surface with the other.
2. Materials and methods
2.1. Collagen matrices
The scaffold used was Chondrogide and was a kind gift from Geistlich Bioma-
terials, Wolhusen, Switzerland. The membrane is a bilayered structure composed of
porcine type I and type III collagens with a smooth, dense side and a rough porous
side. Each scaffold was individually packed after g-irradiation in 30 40 mm sheets,
with a thickness of 1.5–2.0 mm. For experiments, 8 mm discs were punched from
the sheet of scaffold using a dermal biopsy punch (Schuco International London Ltd).
2.2. Cartilage explants
Tissue from adult (24–30months old) cows were obtained at a local abattoir and
used within a few hours of slaughter. Natural cartilage cylinders (8 mm in diameter
and 4.0 mm thick) were harvested from adult bovine nasal cartilage using a dermal
biopsy punch (Schuco International London Ltd). The discs were 8 mm diame-
ter 4 mm thickness, obtained from the middle of nasal septum. They were rinsed
and incubatedwith phosphate buffered saline (PBS) containing 10% (v/v) Penicillin G
(10,000 units/ml)/streptomycin (10,000 mg/ml) antibiotic mixture (P/S; Sigma,
Poole, UK) and 1% (v/v) amphotericin B (250 mg/ml; Sigma) for 20 min. Harvested
nasal cartilage discs was maintained by culture in basic medium containing Dul-
becco’s modiﬁed Eagle’s medium (DMEM, Sigma) with 10 mM Hepes buffer (Sigma),
1.0% (v/v) P/S, 1.0% (v/v) non-essential amino acids (NEAA; Sigma), Glutamax
(Sigma), and 10% amphotericin B (Sigma) at 37 C in a 5% CO2 environment. The
remaining cartilage was used for isolation of chondrocytes.
2.3. Devitalisation
In some experiments the explant discs were subjected to three cycles of freeze/
thawing to kill the chondrocytes. Devitalisationwas evaluated in a group of samples
by measuring lactate concentrations in the culture media before and after freezing/
thawing cycles in a BioProﬁle 400 Analyser (Nova Biomedical, Waltham, USA).
2.4. Cell isolation and expansion
Nasal chondrocytes (BNCs) were obtained from nasal septum cartilage frag-
ments. The fragments were minced in PBS containing 10% (v/v) P/S (Sigma) and 1%
(v/v) amphotericin B (250 mg/ml; Sigma). Chondrocytes were isolated by sequential
digestion at 37 C with 0.25% (w/v) trypsin (Sigma) for 30 min, followed by incu-
bation in 1.5 mg/ml of bacterial collagenase (Sigma) in complete medium containing
10% (v/v) foetal calf serum (FCS, Sigma) at 37 C for 14 h in a rotator. Isolated
chondrocytes were centrifuged and resuspended in Complete Medium containing
DMEM supplemented with basic ﬁbroblast growth factor (FGF-2, 10 ng/ml; Pepro-
tech, London, UK), 10% (v/v) FCS, 1.0% NEAA (Sigma), HEPES buffer (Sigma), P/S
(Sigma), Glutamax (Gibco), and 2.0% (v/v) amphotericin B at 37 C in a 5% CO2
environment. The cells were expanded in Complete Medium containing FGF-2 to
increase their number and inhibit their dedifferentiation in culture [18]. Cells were
expanded in monolayer for one week and for all the experiments cells from the
second passage (P2) were used. The culture medium was changed twice a week.2.5. Cell labeling
In some experiments, chondrocytes were labeled with the ﬂuorescent dye
PKH26 (Sigma) at the end of the isolation and expansion period. The labeling
procedure was performed according to the manufacturer’s protocol. Brieﬂy, after
trypsin release, 10106 cells were washed once in basic medium and resuspended
into 1 ml of dilution buffer provided by the manufacturer in the labeling kit. The cell
suspension were mixed with same volume of the labeling solution containing
PKH26 in a dilution buffer to the ﬁnal concentration of 4 mM. Labeling was allowed
for 7 min at room temperature. The labeling reaction was stopped by adding 1 ml of
FCS. The pellet was transferred to a new tube and washed three times in Complete
Medium before seeding the labeled cells onto scaffolds.2.6. Cell seeding
Collagen scaffolds were seeded with BNCs at a concentration of 1.65106 cells/
cm2 (or 2.5106 cells/scaffold) in 30 ml of complete medium and placed in ultra
low attachment wells of a 24-well plate (Corning, Acton, USA). Seeding was per-
formed in a dropwise fashion onto the scaffold. After 4 h, 1.5 ml of Complete
Medium containing FGF-2 (10 ng/ml) was added and changed daily. Seeded scaffolds
were incubated for 48 h at 37 C in an orbital shaker at 50 rpm.2.7. Assembling and culture of constructs
Sandwich constructs of two bovine nasal septum discs with a seeded scaffold in
betweenwere assembled using skin clips and kept in differentiationmedium in vitro
for up to 40 days. In all groups, sandwich constructs were cultured in ultra low
attachment 6-well plates (Corning, Acton, USA) in expansion complete medium
with FGF-2 (10 ng/ml) for 7 days followed by culture in a differentiation medium
consisting of Complete Medium with insulin (10 mg/ml; Sigma) and long acting
ascorbic acid (50 mg/ml; Sigma) for 33 days. The medium was replenished twice
every week.
The constructs were prepared in several groups: (1) seeded scaffold group
(chondrocyte/collagen-scaffold), (2) unseeded scaffold group (membrane only
control), (3) cells without scaffold group (cells only control) and (4) without scaffold
or cells group (negative control). After 40 days in culture, constructs were divided in
three groups and ﬁxed accordingly: (a) in 10% (v/v) neutral buffered formalin for
histological analysis, (b) frozen and stored at 80 C prior to sectioning for cell
migration, and (c) placed in complete medium containing 10% (v/v) dimethyl sulf-
oxide (DMSO; Sigma) and stored at 80 C prior to biomechanical tests.2.8. Histological analysis
After 40 days in culture the explants were ﬁxed in 10% neutral buffered formalin,
dehydrated and parafﬁn embedded. Samples were then cut into 4 mm sections and
stained with Toluidine blue (Sigma) for assessing morphological details and
proteoglycan distribution.2.9. Histomorphometric image analysis
All histological sections were photographed using a digital Spot camera (Diag-
nostic Instruments Sterling Heights, MI) and histomorphometric analysis was per-
formed with ImagePro Discovery software (Media Cybernetics, Wokingham, UK).
Two perpendicular sections, one at the edge and another at the centre of each
construct, were used for histomorphometric analysis. The entire lengths of the
scaffold/cartilage or cartilage/cartilage (for controls) were measured with a cursor
using a computer mouse to assess the integration. The specimen parameter
measured was Repair Index. The repair index was used to quantify the amount of
integration the scaffold makes with the surrounding cartilage. This parameter is
expressed as a percentage of the total interface lengths of the interface that is
connected or bonded to cartilage [19–22]. In each of the samples, three interfaces
were visible:
1. Unbound Interface (Disintegration), in which there is no apposition or bonding
between the scaffold and surrounding tissues.
2. Bonded Interface (Apposition), scaffold and cartilage are in direct apposition
but there is still a clear demarcation of the cell scaffold.
3. Integrated Interface (Integration), the scaffold/cartilage interface is not only
joined and continuous but there is no clear demarcation of the interface, with
cell migration and matrix remodelling being clearly visible.
To calculate the repair index, we applied the following equations:
% Disintegration ¼ ðd1þ d2Þ
dt
 100
d1 and d2¼ unbound interface (length, mm), dt¼ total interface (mm).
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dt
 100d3 and d4¼ bonded interface (length, mm), dt¼ total interface (mm).
% Integration ¼ ðd5þ d6Þ
dt
 100
d5 and d6¼ integrated interface (length, mm), dt¼ total interface (mm).
2.10. Cell migration
Construct seeded with cells labeled with the red ﬂuorescence PKH26 dye were
frozen and later embedded in O.C.T. compound (BDH Chemical, London, UK). 7 mm
sections were obtained using a cryostat (Cryosect, Seward Ltd, UK). Slides were air
dried for at least 1 h at room temperature and mounted using 1–2 drops DPX
mounting media (Fisher Scientiﬁc Ltd, Leicestershire, UK). Images of samples were
then obtained using a ﬂuorescence microscope. Sections from the same area were
also stained with Toluidine blue as a point of reference and comparison. Labeled
cells migrating or crossing the scaffold-cartilage interface were observed and pho-
tographed to determine if any cell migration occurred.
2.11. Biomechanical tests
After 40 days in culture, chondrocyte/collagen-scaffold implant and control
constructs were placed in Complete Medium containing 10% (v/v) DMSO and stored
at 80 C until mechanical testing. Before testing, samples were thawed and skin
clips removed. Thickness and diameter were recorded for each sample using
a caliper. Construct thickness ranged from 4.0 to 6.0 mm. Construct diameter was
approximately 8 mm. The construct was mounted in the lower half of the holding
device of an Instron 6022mechanical testing frame (Instron, HighWycombe, UK), by
clamping the ‘‘lower’’ half of the construct disc between two sliding Perspex sheets
ﬁtted with needles to affect gripping and bolted to the Instron (Fig. 5A). The upper
half of the device with similar Perspex sheets was closed around the ‘‘upper’’ half of
the construct and in turn held in the pneumatic clamp of the Instron. Load/
displacement data was logged throughout testing to failure using a 486 PC equipped
with series IX data acquisition and analysis software (Instron). This data was used to
build a load/deformation curve from which the maximum load at failure (Fmax) at
the interface cartilage/scaffold was obtained. Maximum tensile stress (MPa) was
then calculated as Fmax [N]/original cross sectional area [mm
2].
2.12. Statistical analysis
For mechanical testing, multiple groups were compared by 2 way ANOVA with
p< 0.05 taken as signiﬁcant. Where signiﬁcant variance was demonstrated, differ-
ences between individual groups were then determined using the two-tailed Stu-
dent’s t-test with a Bonferroni post hoc correction. p< 0.05 was taken as signiﬁcant.
For histomorphometric analysis, multiple groups were compared by analysis of
variance using the non-parametric Kruskal–Wallis test with p< 0.05 taken as
signiﬁcant. Where signiﬁcant variance was demonstrated, differences between
individual groups were then determined using the two-tailedMann–WhitneyU-test
with a Dunn’s post hoc correction. p< 0.05 was taken as signiﬁcant.
3. Results
3.1. Macroscopic appearance of cartilage integration
In order to investigate if chondrocytes seeded onto a sheet of
biomaterial will facilitate the bonding and integration of fully
mature cartilage, we developed a cartilage integration model
comprising a chondrocyte/collagen-scaffold implant sandwiched
between two discs of mature cartilage (Fig. 1A). The sandwiched
constructs were allowed to mature in culture conditions that
support matrix deposition. After 40 days in culture, the construct
appeared as one piece showing the integrating chondrocyte/
collagen-scaffold implant as a very faint line between the bonding
cartilage pieces (Fig. 1D). The negative control (no cells or
membrane) showed no evidence of integration (Fig. 1B) whilst the
membrane only control (cell-free collagen scaffold) showed some
apparent integration, but not as marked as that observed when the
chondrocyte seeded scaffold implant was used (Fig. 1C).
3.2. Matrix formation at the zone of integration
Constructs created using chondrocyte/collagen-scaffold
implants showed dense tissue that bridged the space between thetwo pieces of cartilage (Fig. 2A), creating a close interface between
the scaffolds and the cartilage. A similar picturewas observedwhen
the cell-free scaffold was used, although the bridging tissue stained
less strongly with Toluidine blue, indicating that a less mature
extracellular matrix had been formed (Fig. 2B). In control
constructs seeded with chondrocytes but without a scaffold
(Fig. 2C) or negative controls (no cell or scaffold implant; Fig. 2D),
there was tissue formation at the edges of the construct but most of
the interface between the cartilage pieces was empty or ﬁlled with
a quite thin cell layer and minimal extracellular matrix.
3.3. The role of endogenous chondrocytes
The observation that cell-free scaffold induced tissue formation
between cartilage pieces (Fig. 2B) suggested that chondrocytes
within the natural cartilage might interact with the scaffold
material and contribute to the integration process. To test this
possibility, constructs were created using devitalised cartilage
(Fig. 3). The chondrocyte/collagen-scaffold formed tissue that
integrated with the surrounding devitalised tissue in a similar way
to that observed when using living cartilage (compare Fig. 3A with
Fig. 2A, respectively) suggesting that implant-induced integration
is largely independent of the endogenous cells. However, when the
scaffold was used without chondrocyte seeding (membrane only),
there was no formation of tissue in the integrating zone between
the devitalised cartilage pieces (Fig. 3B). This contrasts with the
moderate level of tissue formation in this zone with living cartilage
(compare Fig. 3B with Fig. 2B). Control constructs created using
living cells seeded onto devitalised cartilage without a scaffold
were no different to those created using living cartilage (compare
Fig. 3C with Fig. 2C, respectively). Negative control constructs
created from devitalised cartilage without implanted cells or scaf-
fold formed no integrating tissue at all (Fig. 3D).
3.4. Cell migration from scaffold to cartilage
We hypothesized that in order for cartilage integration to occur,
chondrocytes from the scaffold must invade the surrounding tissue
to form a tissue continuum. To test this hypothesis, seeded chon-
drocytes were pre-labeled with a ﬂuorescent dye (PKH26) and the
cells were used to create constructs as described under Materials
andmethods. Migrating cells were clearly observed at the cartilage/
scaffold interface using ﬂuorescence microscopy of tissue cry-
osections (Fig. 4B and C). The scaffold-derived chondrocytes
migrated into the surrounding fresh cartilage tissue (Fig. 4B) and
this process appeared to involve remodelling of the extracellular
matrix, shown by the lack of peri-cellular Toluidine blue staining
around the migrating cells and the increased intensity of staining
along the interface (Fig. 4A). In order to exclude the possibility that
PKH26 was leaching out of the implanted cells and being taken up
by endogenous cells in the cartilage, we performed the same
experiment using devitalised tissue. Once again the scaffold-
derived chondrocytes had the capacity to leave the collagen
membrane and penetrate the cartilage tissue (Fig. 4C), conﬁrming
the chondrocyte/collagen-scaffold implant origin of the labeled
cells.
3.5. Cell migration from cartilage to scaffold
The observation that membrane only implants led to some
matrix formation in the originally empty collagen scaffold (Fig. 2B;
100magniﬁcation) led us to investigate this phenomenon further
using higher power magniﬁcation (200). There was clear
evidence of endogenous chondrocytes from the surrounding tissue
invading the cell-free scaffold and elaborating an extracellular
A Chondrocyte/
collagen-
scaffold
implant  
Cartilage
B C D
Fig. 1. Macroscopic appearance of the zone of cartilage integration. Collagen membranes were seeded with bovine nasal chondrocytes to create a chondrocyte/collagen-scaffold
implant, as described under Materials and methods. The scaffold was placed between two discs of bovine nasal cartilage, as shown in (A). In all cases the pieces of cartilage were
held together using clinical grade skin clips and cultured for 40 days. (B)–(C) Typical examples of the macroscopic appearance of these cartilage integration constructs. Each
photograph shows 2 separate constructs. (B) The negative control (no membrane or cells), (C) the membrane only control (collagen scaffold with no cells) and (D) the chondrocyte/
collagen-scaffold implant (collagen membrane with cells). Arrows indicate the site of integration between the two pieces of cartilage in each construct.
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involve degradation of the extracellular matrix in some areas of the
natural cartilage, adjacent to the collagen membrane, as demon-
strated by loss of Toluidine blue staining. These data suggest that
reverse migration of endogenous cartilage chondrocytes into the
scaffold may play a role in the process of integration.
3.6. Tensile strength of the integration zone
Biomechanical tests were performed to determine the tensile
strength of the interface between chondrocyte/collagen-scaffold
implant and pairs of cartilage discs cultured in vitro. We devised
a new biomechanical test conﬁguration that avoided the classical
use of glue (Fig. 5A). Load increased linearly with displacement
until the maximum (ultimate) load was achieved. At this load,
specimen failed and the construct separated. In all cases, fracture
appeared at the interface region between the scaffold and one of
the cartilage discs. The interface tissue was considered to have
failed at themaximum load, and the tensile strength was calculated
as the measured ultimate load divided by the original surface area,
giving the stress at failure in kPa [9].
The average tensile strength of chondrocyte-scaffold and control
groups (fresh and devitalised) is shown in Fig. 5. Living cartilage
constructs containing the chondrocyte/collagen-scaffold implants
showed greatest tensile strength, at an average of 42 kPa, which
was signiﬁcantly greater than the negative control, which had no
measurable tensile strength (Fig. 5B). Devitalised cartilage
constructs containing the chondrocyte/collagen-scaffold implants
had only limited tensile strength (Fig. 5B), suggesting that inter-
action between the collagen scaffold and endogenous cells is
necessary for maximal integration.
Surprisingly, the cell-free scaffold (membrane only) used with
living tissue also had a measurable and signiﬁcant tensile strength
(Fig. 5C), with a mean of 32 kPa, suggesting that invasion by
endogenous cells and limited extracellular matrix formation is
enough to induce some degree of functional integration. In supportof this conclusion, devitalised tissue implanted with the membrane
only had no measurable tensile strength (Fig. 5C).
Controls with cells only (living or devitalised cartilage and cells
with no membrane) all had no measurable tensile strength (data
not shown).
3.7. Quality of integration
In order to quantify the degree and quality of cartilage inte-
gration in the sandwich constructs, we adapted a histomorpho-
metric repair index [19–22] that we have deﬁned as a percentage of
the total interface length of the scaffold that is connected or bonded
to cartilage. The total potential integration interface was analysed
and the proportion falling into each of three quality parameters
(Fig. 6A) was expressed as a percentage of the total: (1) Disinte-
gration: an open interface in which both surfaces (cartilage/carti-
lage or cartilage/scaffold) remain open, without contact; (2)
Apposition: both surfaces are in contact but there is a clear
demarcation between them; (3) Integration: a fully integrated
interface in which there is no clear demarcation, characterised by
cell migration and matrix remodelling.
Using this histomorphometric approach, we observed that there
was a high level of disintegration in negative controls (no scaffold
or cells) and constructs seeded with cells but without a scaffold,
accounting for approximately 100% and 75%, respectively of the
total interface (Fig. 6B). In constructs with membrane only (cell-
free scaffold), or chondrocyte/collagen-scaffold implants (cells
seeded onto scaffold), there was little disintegration, accounting for
just 25% of the interface, which was signiﬁcantly lower than the
negative control.
Appositionwas observed in all constructs containing cell-loaded
or unloaded scaffold as well as constructs with cells only (Fig. 6C).
There was very little apposition (less than 16%) in negative controls.
The percentage of appositionwas found to be signiﬁcantly higher in
cell-free scaffold compared to negative controls or cells only
controls.
Fig. 2. Histological appearance of the zone of cartilage integration. Collagen membranes were seeded with bovine nasal chondrocytes to create a chondrocyte/collagen-scaffold
implant, as described under Materials and methods. The scaffold was placed between two discs of bovine nasal cartilage, as shown in Fig. 1A. All constructs and controls were
cultured for 40 days and then processed for histology. Each panel shows a typical parafﬁn embedded section stained with Toluidine blue at 10 magniﬁcation. The images are
compilations of serial lateral sections spanning the full width of the integration zone. (A) The chondrocyte/collagen-scaffold implant. (B) The membrane only control (collagen
scaffold with no cells), (C) the cells only control (chondrocytes seeded onto the surface of each piece of cartilage) and (D) the negative control (no cells and no membrane).
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border) in negative control constructs or those seeded with cells
but no scaffold, whilst the membrane only controls only had up to
3% integration. In contrast, those constructs created using a chon-
drocyte/collagen-scaffold implant showed an extensive integration,
reaching up to 50% of the total interface (Fig. 6D). These results
demonstrate the requirement for the chondrocyte/collagen-scaf-
fold implant scaffold in order to produce a clear integration with
loss of the demarcating border between cartilage and implant.
4. Discussion
We set out to test the hypothesis that integration of cartilage
with cartilage requires migration of chondrocytes between the
two surfaces. We have demonstrated that this is the case and that
the migrating chondrocytes may be derived either from cells that
have been grown in vitro and then seeded onto a collagen
membrane, or from the cartilage tissue itself. Our observation that
a cell-free collagen membrane may stimulate cartilage integration
with some degrees of mechanical stability was unexpected. The
observation, however, may be misleading because the quality of
integration was not as good as that achieved with the c chon-
drocyte/collagen-scaffold implant. With the cell-free scaffold there
was no loss of a demarcating border, only apposition of cartilage
tissue with the membrane and partial ﬁlling of the membrane
with new extracellular matrix. It seems reasonable to presumethat any mechanical stability provided by this partial integration
will be transient, because the collagen membrane is biodegradable
and so cannot provide a permanent focus for integration. In
contrast, the loss of demarcating border observed with the
chondrocyte/collagen-scaffold implant indicates an integration
that is likely to be stable over time because of the continuous
nature of the extracellular matrix across the cartilage/implant
interface, and is likely to increase as new matrix is deposited. It
remains possible that alternative biomaterials with a longer half-
life could be developed as cell-free implants for inducing
integration.
Until now, there has been no consistent method for assisting the
integration of mature cartilage implants with host tissue. Building
on ourmethods for cartilage tissue engineering using different cells
and biomaterials [6,23], we have explored the factors that are most
important in driving an effective integration between tissues. We
used tensile testing to measure any increase in mechanical stability
and histomorphometry to estimate the quality of integration, as an
indicator of longevity of the integration, with loss of the demar-
cating border as the decisive factor. Furthermore we explored the
role of cell migration through the use of PKH26, a vital dye that
permitted the microscopic tracking of the scaffold chondrocytes
across the interface. We also explored the role of chondrocytes
within the natural cartilage through comparison of living and
devitalised tissue. In this way we have built up a comprehensive
picture of the key factors that regulate integration.
AB
400µm 
C
Chondrocyte/collagen-scaffold implant
Negative control D
Cells only
Membrane only
Fig. 3. Histological appearance of the zone of integration using devitalised cartilage. Collagen membranes were seeded with bovine nasal chondrocytes to create a chondrocyte/
collagen-scaffold implant, as described under Materials and methods. The scaffold was placed between two discs of bovine nasal cartilage, as shown in Fig. 1A, that had been
devitalised by repeated freeze-thawing. All constructs and controls were cultured for 40 days and then processed for histology. Each panel shows a typical parafﬁn embedded
section stained with Toluidine blue at 10magniﬁcation. The images are compilations of serial lateral sections spanning the full width of the integration zone. (A) The chondrocyte/
collagen-scaffold implant. (B) The membrane only control (collagen scaffold with no cells), (C) the cells only control (chondrocytes seeded onto the surface of each piece of
devitalised cartilage) and (D) the negative control (no cells and no membrane).
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integration. When cells alone were used there was some ﬁlling of
the space with proliferating cells but little or no extracellular
matrix to bind the pieces of cartilage together. Therefore there was
no integration and limited apposition. The collagen membrane on
its own led to a moderate degree of extracellular matrix formation
and this was a result of inﬁltration of the membrane by cells
migrating from the cartilage. The mechanism by which this inﬁl-
tration was stimulated by the collagen is unknown, but it appar-
ently involved some degradation of the proteoglycan in the
extracellular matrix at the junction of the cartilage and scaffold
(Fig. 4D). This moderate degree of matrix formation neverthelessled to an increase in tensile strength that was almost as great as that
achieved using the chondrocyte/collagen-scaffold implant.
However detailed histomorphometric analysis demonstrated very
little true integration as the demarcating border was still clear
throughout the integration zone. Therefore, although the collagen
membrane is an essential component for driving the integration
process, it is clearly not sufﬁcient for a long-term, stable outcome.
However combining the collagen membrane with chondrocytes
into a chondrocyte/collagen-scaffold implant did lead to complete
loss of the demarcating border in up to 50% of the integration zone
after just 40 days of in vitro culture. Fluorescent labeling demon-
strated clearly that the implanted chondrocytes migrated from the
Ccartilage 
chondrocyte/collagen-scaffold implant 
A B
D
chondrocyte/collagen-scaffold implant 
cartilage 
100 microns
100 microns
cartilage 
chondrocyte/collagen-scaffold implant 
chondrocyte/collagen-scaffold implant 
cartilage 
Fig. 4. Cell migration in cartilage integration constructs. Cell migration from the chondrocyte/collagen-scaffold implant to the surrounding nasal cartilage was determined by pre-
labeling the bovine nasal chondrocytes with ﬂuorescent dye PKH26 before seeding them onto collagen membranes, as described under Materials and methods. In (A) and (B) the
pre-labeled chondrocyte/collagen-scaffold implant was inserted between two pieces of living bovine nasal cartilage and one of the two interfaces is shown. (A) Stained with
Toluidine blue and viewed under white light whilst (B) is viewed under ﬂuorescent light (both 200 magniﬁcation). Arrows indicate cells in the process of migrating across the
border between the cartilage and the membrane. (C) Cell migration from the collagen membrane into devitalised cartilage (200 magniﬁcation). In (D), migration of endogenous
chondrocytes from surrounding cartilage into the collagen membrane was determined in membrane only constructs (i.e., no implanted cells), stained with Toluidine blue (100
magniﬁcation). Areas of cell inﬁltration and matrix formation are indicated with arrows.
M.B. Pabbruwe et al. / Biomaterials 30 (2009) 4277–4286 4283collagen membrane into the cartilage and histological analysis
showed that an extensive extracellular matrix formed between the
two pieces of cartilage, creating a continuum of tissue.
Although we have gone some way to deﬁning the factors that
are most important in cartilage integration, there remain a number
of questions that must be answered if this chondrocyte/collagen-
scaffold implant approach is to be developed as a practical method
for implanting engineered tissue. In this study we have used
a single type of collagen membrane and a single cell type, bovine
nasal chondrocytes, future studies will need to extend our work to
explore the use of articular chondrocytes and stem cells as alter-
natives. Secondly, we have demonstrated an increase in tensile
strength after 40 days in vitro, however successful tissue survival in
vivo will require a much greater degree of integration with a far
larger increase in tensile strength. Therefore longer term studies
and in vivo implantation studies are required in order to determine
if this approach is viable clinically.
A range of methods has been developed for the repair of
articular cartilage lesions [10,24]. These include osteochondral
transplantation [25], microfracture [26] and autologous chon-
drocyte implantation (ACI) [27,28] with or without the assistance of
a scaffold matrix to deliver the cells [29]. A feature of all of these
techniques is that their use is limited to the repair of focal lesions
and patients with osteoarthritis (OA) are mostly excluded from
treatment. OA cartilage lesions are generally large and unconﬁned
[30] and so do not provide an appropriate environment for chon-
drocytes or stem cells to be retained long enough to elaborate anextracellular matrix. Therefore successful repair of OA cartilage
lesions is only likely to be achieved when mature, three-dimen-
sional cartilage implants can be generated that have enough
extracellular matrix for ﬁxation and permanent integration within
the joint.
A number of studies have investigated methods for enhancing
integration of cartilage with cartilage. Bos et al. [31] investigated
the effects of enzymic matrix digestion on cartilage integration.
Their hypothesis was that accumulation of dead cells at the wound
edge inhibits integration and removal of this layer of tissue leads to
a higher number of living cells at the wound edge and therefore
better apparent integration. However their study did not include
anymechanical testing and it was unclear if the induced integration
was in any way functional. Redman et al. investigated the effects of
trauma on chondrocyte apoptosis [8]. They demonstrated that
blunt trauma led to a signiﬁcant increase in apoptosis at the wound
edge compared to injury with a sharp instrument. They concluded
that integration could be enhanced by avoiding blunt traumas
during surgery or by inhibiting apoptosis. Peretti has undertaken
a series of studies investigating the use of chondrocytes to promote
cartilage integration [17,32]. This method involves seeding chon-
drocytes onto a piece of devitalised cartilage matrix and sand-
wiching this piece between two pieces of natural cartilaginous
tissue. These constructs were then allowed to mature in vivo in
a sub-cutaneous pouch of nude mice, leading to enhanced inte-
gration that was dependent on the seeded cells. Taken together the
studies described above highlight the importance of a fall in viable
Fig. 5. Mechanical strength of integrated cartilage. Collagen membranes were seeded with bovine nasal chondrocytes to create a chondrocyte/collagen-scaffold implant, as
described under Materials and methods. The chondrocyte/collagen-scaffold implant was placed between two discs of living or devitalised bovine nasal cartilage and cultured for 40
days. Tensile strength was determined as described under Materials and methods. (A) A diagram of the new biomechanical test conﬁguration, described under Material and
methods. (B) Results using the chondrocyte/collagen-scaffold implant and (C) the results using a membrane only control (i.e., no implanted cells). In both panels the negative control
(no implanted cells or membrane) is shown for comparison. Each bar is the mean SEM (n¼ 3–5). Data were analysed by ANOVA followed by a Student’s t-test with a post hoc
Bonferroni correction for multiple comparisons. *p< 0.05; **p< 0.01; NS¼ not signiﬁcant.
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Fig. 6. Histomorphometric analysis of cartilage integration. Collagen membranes were seeded with bovine nasal chondrocytes to create a chondrocyte/collagen-scaffold implant, as
described under Materials and methods. The scaffold was placed between two discs of bovine nasal cartilage, as shown in Fig. 1A. Controls included cells with no membrane, seeded
onto the surface of each piece of cartilage (cells only control), collagen scaffold with no cells (membrane only control) and no membrane or cells (negative control). In all cases the
constructs were cultured for 40 days and then processed for histology. Morphometric analysis was used to measure the quality of integration across the complete integrating
interface (i.e., the full length of both cartilage surfaces). The classiﬁcation of morphological patterns is shown in (A). The % of integrating surface falling into each morphological
category was calculated as described under Materials and methods. (B) The % disintegration, (C) the % apposition and (D) the % integration. Each bar is the mean SEM (n¼ 3–5).
Data were analysed by Kruskal–Wallis non-parametric ANOVA followed by a Mann–Whitney U-test with a post hoc Dunn correction for multiple comparisons. *p< 0.05; **p< 0.01.
All comparisons not indicated were not signiﬁcant.
M.B. Pabbruwe et al. / Biomaterials 30 (2009) 4277–4286 4285chondrocyte number in preventing integration of tissues and the
need for a cell based strategy to enhance integration. Our work
described here conﬁrms the conclusions of these earlier studies and
extends this body of work by demonstrating a role of both
implanted cells and endogenous chondrocytes and by highlighting
the key role of the collagen membrane in bringing the two cartilage
surfaces together and initiating the integration response. It is
important to note that, unlike the devitalised cartilage scaffoldsused by Peretti, the Chondrogide scaffolds used in this study are
thin sheets, ensuring a small distance between the two cartilage
surfaces. This is likely to be important for production of
a continuum of tissue. It should be further noted that the extensive
integration induced by our chondrocyte/collagen-scaffold implant
was achieved after 40 days of culture in vitro in standard culture
conditions. It can be expected that implantation in vivo would
enhance this integrative response [17,32].
M.B. Pabbruwe et al. / Biomaterials 30 (2009) 4277–42864286In summary, we have provided new evidence to support the
hypothesis that cell migration between cartilage surfaces is critical
for integration of those tissues. The chondrocytes may be derived
from the natural cartilage, from implanted scaffolds, or both. The
scaffold design is also a critical factor as it can play a role in aligning
the surfaces of cartilage and stimulating migration of the endoge-
nous cells. Studies of our chondrocyte/collagen-scaffold implant
using in vivomodels of cartilage repair are required to determine if
the integrative response that is initiated is mechanically stable
under normal load in the joint. Further studies are also required to
determine if the chondrocyte/collagen-scaffold implant approach
could be used to integrate other types of tissue.5. Conclusions
Our results suggest that cartilage integration can be achieved
using a chondrocyte/collagen-scaffold implant that permits simple,
active and controlled delivery of chondrocytes to both host and
graft mature cartilage tissues. The collagen membrane is required
to promote apposition of the cartilage surfaces and initiates inward
migration by endogenous chondrocytes whilst the seeded cells are
required to promote extracellular matrix remodelling in the zone of
integration. This combined cell and membrane approach has the
potential to be used therapeutically for implantation of cartilage
engineered tissue as well as repair of meniscal cartilage tears.Acknowledgments
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